ArticleBMC cancer2020

Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010-2016.

Thomas M Schwedhelm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.